HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

advanced glycation end products-human serum albumin

Also Known As:

AGE-HSA; GEPA-HSA; glycosylation end products, human serum albumin

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Albumins: 31532
    - Serum Albumin: 9893
      - Human Serum Albumin: 2275
        advanced glycation end products-human serum albumin: 4
  - Blood Proteins: 12459
    - Serum Albumin: 9893
      - Human Serum Albumin: 2275
        advanced glycation end products-human serum albumin: 4
Carbohydrates: 22023
- Glycoconjugates: 1353
  - Advanced Glycation End Products: 4609
    - advanced glycation end products-human serum albumin: 4
Biological Factors: 2472
- Biological Toxins: 20
  - Advanced Glycation End Products: 4609
    - advanced glycation end products-human serum albumin: 4

Experts

1.	Gohil, N K: 1 article (01/2015)
2.	Nirala, B K: 1 article (01/2015)
3.	Carpenter, Andrea J: 1 article (01/2013)
4.	Chandrasekar, Bysani: 1 article (01/2013)
5.	Das, Nitin A: 1 article (01/2013)
6.	Delafontaine, Jean-Luc: 1 article (01/2013)
7.	Siebenlist, Ulrich: 1 article (01/2013)
8.	Valente, Anthony J: 1 article (01/2013)
9.	Venkatesan, Balachandar: 1 article (01/2013)
10.	Yoshida, Tadashi: 1 article (01/2013)

Related Diseases

1.	Atherosclerosis 01/01/2009 - "AGE-HSA could promote atherosclerosis by upregulating EPCs RAGE expressions and promoting EPCs apoptosis via p38, ERK MAPK pathways, activation of NF-kappaB might also play a role in this process."
2.	Inflammation (Inflammations) 01/01/2015 - "The data suggest that SACSO exerts an attenuating effect on 20 mM glucose derived AGE-HSA induced inflammation, by selectively inhibiting RAGE while stimulating galectin-3 expression. "
3.	Hyperglycemia 01/01/2013 - "Similar to HG, the deleterious metabolic products of chronic hyperglycemia, AGE-HSA, AOPPs-HSA and oxLDL, also induced CIKS-dependent endothelial dysfunction. "
4.	Hypoxia (Hypoxemia) 10/01/2012 - "On the other hand sICAM-1 was up-regulated by AGE-HSA but down-regulated by hypoxia. " 10/01/2012 - "However, when the cells were exposed to a combination treatment of hypoxia and AGE-HSA, a biphasic effect at the two different concentrations was observed as compared to the individual treatments. " 10/01/2012 - "VEGF was synergistically up-regulated by hypoxia and AGE-HSA. " 10/01/2012 - "Therefore we have examined the interaction of glycation modified human serum albumin (AGE-HSA) and deferoxamine (DFO) mimicked hypoxia on the expression of hypoxia inducible factor 1α (HIF-1α), and the role of RAGE (receptor for AGE) signaling in up-regulation of HIF-1α. "

Related Drugs and Biologics

1.	Advanced Oxidation Protein Products (AOPP)
2.	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
3.	Galectin 3 (LGALS3)
4.	NF-kappa B (NF-kB)
5.	Glucose (Dextrose)
6.	Deferoxamine (Desferal)
7.	Human Serum Albumin
8.	oxidized low density lipoprotein